title: The authors reply.
authors.affiliation: Department of Intensive Care Medicine, Raymond Poincaré Hospital, Garches, France; CoDivision of Critical Care Medicine, Cooper Medical School of Rowan University, Cooper Health Systems, Camden, NJ.
authors.forename: Djillali
authors.initials: D
authors.lastname: Annane
authors.forename: R Phillip
authors.initials: RP
authors.lastname: Dellinger
mesh_terms: D003422:Critical Care / Q000592:standards*; D004298:Dopamine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000627:therapeutic use*; D018805:Sepsis / Q000175:diagnosis* / Q000628:therapy*; D012769:Shock / Q000188:drug therapy*; D012772:Shock, Septic / Q000188:drug therapy*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
chemical_list: D014662:Vasoconstrictor Agents; D004298:Dopamine; D009638:Norepinephrine